Quick Answer
enVVeno Medical Corp reported Cash And Cash Equivalents At Carrying Value of $3.07 million for the year ending 2025.
- enVVeno Medical Corp showed an increase of +74.7% in Cash And Cash Equivalents At Carrying Value from 2024 to 2025.
- This data is from enVVeno Medical Corp's annual report (Form 10-K), filed with the SEC on March 26, 2026.
- XBRL data for this metric is available from 2016 to 2025 (10 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q3 2017: $311.5 thousand | Q4 2017: $77.7 thousand | Q1 2018: $309.1 thousand | Q3 2018: $4.19 million | Q1 2019: $2.75 million | Q2 2019: $4.47 million | Q3 2019: $2.94 million | Q1 2020: $720.1 thousand | Q2 2020: $1.56 million | Q3 2020: $5.63 million | Q1 2021: $43.84 million | Q2 2021: $41.04 million | Q3 2021: $57.90 million | Q1 2022: $51.34 million | Q2 2022: $9.07 million | Q3 2022: $2.90 million | Q1 2023: $2.27 million | Q2 2023: $4.71 million | Q3 2023: $4.95 million | Q1 2024: $2.31 million | Q2 2024: $2.38 million | Q3 2024: $17.92 million | Q1 2025: $2.94 million | Q2 2025: $2.04 million | Q3 2025: $1.54 million.
- Over the full 10 years of available data (2016 to 2025), enVVeno Medical Corp's Cash And Cash Equivalents At Carrying Value has grown by 5,323.4%.
- Historical annual values: Fiscal year 2025: $3.07 million | Fiscal year 2024: $1.75 million | Fiscal year 2023: $3.62 million | Fiscal year 2022: $4.56 million | Fiscal year 2021: $54.73 million | Fiscal year 2020: $9.33 million | Fiscal year 2019: $1.31 million | Fiscal year 2018: $2.74 million | Fiscal year 2017: $77.7 thousand | Fiscal year 2016: $56.5 thousand.
- Data sourced from SEC EDGAR public filings as of August 9, 2026.
Last verified: